GlassScriptPhysician profile
Aaron G Margulies
NPI 1255358982
$2,202.42
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2021: $341 · 2022: $378 · 2023: $675 · 2024: $605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,279.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $545.02 | 2021-2024 | Myrisk |
| Vector Surgical, LLC | $300.11 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $220.65 | 2019-2024 | Tagrisso, Enhertu |
| Molli Surgical (US) INC | $180.62 | 2022 | |
| Hologic Sales and Service, LLC | $146.44 | 2024 | Localizer |
| Puma Biotechnology, INC. | $133.73 | 2021-2023 | Nerlynx |
| Janssen Pharmaceuticals, INC | $124.99 | 2021 | |
| Merck Sharp & Dohme LLC | $91.37 | 2021-2023 | Lynparza, Keytruda |
| Genentech USA, INC. | $68.10 | 2019 | |
| Paratek Pharmaceuticals, INC. | $57.54 | 2022-2023 | Nuzyra |
| Sirius Medical Systems | $57.18 | 2023 | Pintuition |
| Angiodynamics, INC. | $33.25 | 2019 | |
| Medtronic, INC. | $31.43 | 2023 | Venaseal |
| Regeneron Healthcare Solutions, INC. | $28.22 | 2023 | Libtayo |
| Merit Medical Systems INC | $22.94 | 2023 | Savi Scout, Savi Brachy |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $22.34 | 2023 | |
| Daiichi Sankyo INC. | $21.44 | 2023 | Injectafer |
| Takeda Pharmaceuticals U.S.A., INC. | $19.03 | 2023 | Ninlaro |
| Morphosys, US INC. | $18.86 | 2023 | Monjuvi |
| Sanara Medtech INC. | $18.63 | 2022 | |
| Mirati Therapeutics, INC. | $17.55 | 2023 | Krazati |
| Amgen INC. | $16.07 | 2023 | Nplate, Vectibix, Xgeva |
| Gilead Sciences, INC. | $15.04 | 2023 | Trodelvy |
| Covidien LP | $11.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Margulies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.